company background image
SOT logo

Société de Therapeutique Marocaine CBSE:SOT Stock Report

Last Price


Market Cap







20 Jun, 2024


Company Financials

Société de Therapeutique Marocaine S.A.

CBSE:SOT Stock Report

Market Cap: د.م7.4b

SOT Stock Overview

Societe de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco.

SOT fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance2/6
Financial Health4/6


Risk Analysis

No risks detected for SOT from our risk checks.

Société de Therapeutique Marocaine S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Société de Therapeutique Marocaine
Historical stock prices
Current Share Priceد.م1,030.00
52 Week Highد.م1,240.00
52 Week Lowد.م923.00
11 Month Change3.00%
3 Month Change-0.67%
1 Year Change-16.94%
33 Year Change-6.36%
5 Year Change142.35%
Change since IPO672.51%

Recent News & Updates

Recent updates

Shareholder Returns

SOTMA PharmaceuticalsMA Market

Return vs Industry: SOT underperformed the MA Pharmaceuticals industry which returned 22.3% over the past year.

Return vs Market: SOT underperformed the MA Market which returned 13.8% over the past year.

Price Volatility

Is SOT's price volatile compared to industry and market?
SOT volatility
SOT Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.5%
10% most volatile stocks in MA Market7.9%
10% least volatile stocks in MA Market2.2%

Stable Share Price: SOT has not had significant price volatility in the past 3 months.

Volatility Over Time: SOT's weekly volatility (4%) has been stable over the past year.

About the Company


Societe de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco. It offers products in various therapeutic areas, including allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and other generic drugs. The company also provides its products in various forms, such as tablets, capsules, pouches, syrups, suspensions, powders, collyriums, suppositories, creams and pomades, injectable solutions, and self-injectable syringes.

Société de Therapeutique Marocaine S.A. Fundamentals Summary

How do Société de Therapeutique Marocaine's earnings and revenue compare to its market cap?
SOT fundamental statistics
Market capد.م7.42b
Earnings (TTM)د.م262.76m
Revenue (TTM)د.م2.49b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SOT income statement (TTM)
Cost of Revenueد.م1.34b
Gross Profitد.م1.15b
Other Expensesد.م888.20m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date


Earnings per share (EPS)36.49
Gross Margin46.30%
Net Profit Margin10.57%
Debt/Equity Ratio33.0%

How did SOT perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.